CUFinder

Ruchi Saxena

Ruchi Saxena

Duke University

H-index: 14

North America-United States

Contact Ruchi Saxena

About Ruchi Saxena

Ruchi Saxena, With an exceptional h-index of 14 and a recent h-index of 10 (since 2020), a distinguished researcher at Duke University, specializes in the field of Cancer Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Complement factor H: a novel innate immune checkpoint in cancer immunotherapy

Creation of a favorable antitumor microenvironment by the anti-complement factor H antibody mGT103

Antitumor immune mechanisms of the anti-complement factor H antibody GT103

Class I PI3K provide lipid substrate in T cell autophagy through linked activity of inositol phosphatases

ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma

CXCR4 inhibition modulates the tumor microenvironment and retards the growth of B16-OVA melanoma and Renca tumors

Ruchi Saxena Information

University

Position

and Medical Center

Citations(all)

561

Citations(since 2020)

258

Cited By

400

hIndex(all)

14

hIndex(since 2020)

10

i10Index(all)

15

i10Index(since 2020)

10

Email

University Profile Page

Google Scholar

Ruchi Saxena Skills & Research Interests

Cancer Immunology

Top articles of Ruchi Saxena

Complement factor H: a novel innate immune checkpoint in cancer immunotherapy

2024/2/8

Ruchi Saxena
Ruchi Saxena

H-Index: 9

Jian Guo
Jian Guo

H-Index: 17

Creation of a favorable antitumor microenvironment by the anti-complement factor H antibody mGT103

2023/7/7

Antitumor immune mechanisms of the anti-complement factor H antibody GT103

Molecular Cancer Therapeutics

2023/6/1

Ruchi Saxena
Ruchi Saxena

H-Index: 9

Class I PI3K provide lipid substrate in T cell autophagy through linked activity of inositol phosphatases

Frontiers in Cell and Developmental Biology

2021/8/12

Ruchi Saxena
Ruchi Saxena

H-Index: 9

ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma

Science translational medicine

2021/1/20

Ruchi Saxena
Ruchi Saxena

H-Index: 9

Seema Amin
Seema Amin

H-Index: 1

Andrew Moore
Andrew Moore

H-Index: 3

Ziad Bakouny
Ziad Bakouny

H-Index: 14

Sabina Signoretti
Sabina Signoretti

H-Index: 76

Thomas Walther
Thomas Walther

H-Index: 8

CXCR4 inhibition modulates the tumor microenvironment and retards the growth of B16-OVA melanoma and Renca tumors

Melanoma research

2020/2/1

Ruchi Saxena
Ruchi Saxena

H-Index: 9

Yan Wang
Yan Wang

H-Index: 2

See List of Professors in Ruchi Saxena University(Duke University)